Close Menu

NEW YORK (GenomeWeb) – Abbott today said that its Diagnostics business grew sales 43 percent year over year.

For the three months ended Sept. 30, 2018 the Abbott Park, Illinois-based firm reported overall revenues of $7.66 billion, up 12 percent on a reported basis from $6.83 billion a year ago. Organically, revenues grew 8 percent. The company beat the consensus Wall Street estimate of $7.65 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.